ArticleRSC advances2025
Engineering MXene/metal composites from MAX phase/metal-Al precursors for high-performance energy conversion and storage.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hierarchically Porous Mullite Ceramics Assembled from Ultrathin Nanosheets for High-Temperature Thermal Insulation.Materials (Basel, Switzerland) · 2026Article
- Early-d-metal Janus MXenes as near-thermoneutral hydrogen evolution electrocatalysts: role of anion identity and d-band asymmetry.RSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Two-dimensional (2D) transition metal carbides, MXenes, have garnered significant interest for their potential applications in various energy storage and conversion systems. This work presents a novel approach to synthesizing MXene/metal composites
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.